Cargando…

Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia

BACKGROUND: An oral tetra-arsenic tetra-sulfide (AS(4)S(4)) formula has been recommended as an outpatient post-remission treatment for Chinese adults with acute promyelocytic leukemia (APL) but limited data are available for children. In this exploratory study, we aimed to evaluate the pharmacokinet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Yang, Xin-Mei, Chen, Jing, Hu, Lei, Yang, Fan, Zhou, Yue, Zhao, Bei-Bei, Zhao, Wei, Zhu, Xiao-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071704/ https://www.ncbi.nlm.nih.gov/pubmed/33911851 http://dx.doi.org/10.2147/DDDT.S305244

Ejemplares similares

Barium dierbium(III) tetrasulfide
por: Mesbah, Adel, et al.
Publicado: (2013)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia
por: Luo, Jie-Si, et al.
Publicado: (2023)

Pharmacokinetic Characteristics, Tissue Bioaccumulation and Toxicity Profiles of Oral Arsenic Trioxide in Rats: Implications for the Treatment and Risk Assessment of Acute Promyelocytic Leukemia
por: Liu, Wensheng, et al.
Publicado: (2021)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
por: Yang, Ming‐Hua, et al.
Publicado: (2018)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

Crystal structure of tetraisobutylthiuram disulfide
por: Fontenot, Patricia R., et al.
Publicado: (2017)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021)

Clinical Value of Serum miRNA in Patients with Acute Promyelocytic Leukemia
por: Zhang, Bei, et al.
Publicado: (2022)

PB2691: ARSENIC RETENTION IN TISSUES AND QUALITY OF LIFE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ARSENICALS: A CROSS SECTIONAL STUDY
por: Wu, Chao, et al.
Publicado: (2023)

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022)

Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
por: Tinajero, Jose, et al.
Publicado: (2022)

Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies
por: Hirano, Seishiro, et al.
Publicado: (2022)

Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals
por: Fan, Xiao-Yang, et al.
Publicado: (2016)

Advances in Pediatric Acute Promyelocytic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line
por: Baek, Jin Ho, et al.
Publicado: (2012)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
por: McCulloch, Derek, et al.
Publicado: (2017)

Bis(tetramethylammonium) thiosulfate tetrahydrate
por: Yang, Yun-Xia, et al.
Publicado: (2011)

Tetraaquabis[5-(3-pyridyl)tetrazolido-κN (5)]zinc(II) tetrahydrate
por: Mu, Yi-Qiang, et al.
Publicado: (2010)

Disodium tricopper(II) tetrakis[selenate(IV)] tetrahydrate
por: Liu, Wei, et al.
Publicado: (2008)

Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy
por: Rosati, Giorgio, et al.
Publicado: (2023)

Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
por: Li, Tao, et al.
Publicado: (2018)

Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein
por: Tian, Yuwang, et al.
Publicado: (2014)

Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
por: Yedjou, Clement, et al.
Publicado: (2009)

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia
por: Ganesan, S, et al.
Publicado: (2016)

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
por: Masciarelli, S, et al.
Publicado: (2018)

Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic
por: Winterfield, Jeffrey R., et al.
Publicado: (2015)

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
Publicado: (2017)

Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia: A Systematic Review
por: Mohammadi Kanesbi, Mehdi, et al.
Publicado: (2020)

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide
por: Hashimoto, Akiko, et al.
Publicado: (2021)

Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
por: Hashimoto, Akiko, et al.
Publicado: (2021)

Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
por: Epstein-Peterson, Zachary D., et al.
Publicado: (2022)

1,4,8,11-Tetraazoniacyclotetradecane tetrachloridocobaltate(II) dichloride
por: Ferchichi, Tarek, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7lak8o32r9osv62ie3sl9sjdof